[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20022590L - Nye tri-substituerte fenylderivater og analoge - Google Patents

Nye tri-substituerte fenylderivater og analoge

Info

Publication number
NO20022590L
NO20022590L NO20022590A NO20022590A NO20022590L NO 20022590 L NO20022590 L NO 20022590L NO 20022590 A NO20022590 A NO 20022590A NO 20022590 A NO20022590 A NO 20022590A NO 20022590 L NO20022590 L NO 20022590L
Authority
NO
Norway
Prior art keywords
analogs
substituted phenyl
phenyl derivatives
new tri
tri
Prior art date
Application number
NO20022590A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022590D0 (no
Inventor
Maria Boije
Jonas Faegerhag
Eva-Lotte Lindstedt Alstermark
Bengt Ohlsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20022590D0 publication Critical patent/NO20022590D0/no
Publication of NO20022590L publication Critical patent/NO20022590L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20022590A 1999-12-03 2002-05-31 Nye tri-substituerte fenylderivater og analoge NO20022590L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904421A SE9904421D0 (sv) 1999-12-03 1999-12-03 New compounds
PCT/SE2000/002385 WO2001040172A1 (en) 1999-12-03 2000-11-29 New tri-substituted phenyl derivatives and analogues

Publications (2)

Publication Number Publication Date
NO20022590D0 NO20022590D0 (no) 2002-05-31
NO20022590L true NO20022590L (no) 2002-07-29

Family

ID=20417986

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022590A NO20022590L (no) 1999-12-03 2002-05-31 Nye tri-substituerte fenylderivater og analoge

Country Status (23)

Country Link
US (1) US6750252B2 (ja)
EP (1) EP1237856B1 (ja)
JP (1) JP2003515583A (ja)
KR (1) KR100787072B1 (ja)
CN (1) CN1206212C (ja)
AR (1) AR033957A1 (ja)
AT (1) ATE266633T1 (ja)
AU (1) AU766533B2 (ja)
BR (1) BR0016130A (ja)
CA (1) CA2392039A1 (ja)
DE (1) DE60010747T2 (ja)
DK (1) DK1237856T3 (ja)
ES (1) ES2219425T3 (ja)
IL (2) IL149517A0 (ja)
MX (1) MXPA02005223A (ja)
MY (1) MY124727A (ja)
NO (1) NO20022590L (ja)
PT (1) PT1237856E (ja)
SE (1) SE9904421D0 (ja)
TR (1) TR200401716T4 (ja)
TW (1) TWI224590B (ja)
WO (1) WO2001040172A1 (ja)
ZA (1) ZA200203798B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
BR9812772A (pt) 1997-10-27 2000-10-10 Reddy Research Foundation "compostos tricìclicos inéditos e o seu emprego na medicina;processo para a sua preparação e composições farmacêuticas contendo os mesmos"
WO1999016758A1 (en) 1997-10-27 1999-04-08 Dr. Reddy's Research Foundation Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
CA2307068C (en) 1997-10-27 2007-04-10 Dr. Reddy's Research Foundation Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
EP1124808A1 (en) 1998-10-29 2001-08-22 Dr. Reddy's Research Foundation An improved process for the preparation of new antidiabetic agents
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds
SE0101386D0 (sv) 2001-04-20 2001-04-20 Astrazeneca Ab New compounds
IL161431A0 (en) * 2001-10-16 2004-09-27 Reddys Lab Ltd Dr beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
UA82835C2 (en) * 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
FR2872159B1 (fr) * 2004-06-28 2007-10-05 Merck Sante Soc Par Actions Si Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
TW200817369A (en) * 2006-05-22 2008-04-16 Elan Pharm Inc Preparation of polymer conjugates of therapeutic, agricultural and food additive compounds
JP5404429B2 (ja) 2007-03-08 2014-01-29 アルビレオ・アクチボラグ ２−置換３−フェニルプロピオン酸誘導体および炎症性腸疾患の治療におけるそれらの使用
FR2917086B1 (fr) 2007-06-05 2009-07-17 Galderma Res & Dev Nouveaux derives d'acide 3-phenyl acrylique activateurs des recepteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
FR2917084B1 (fr) 2007-06-05 2009-07-17 Galderma Res & Dev Nouveaux derives d'acide 3-phenyl propanoique activateurs des recpteurs de type ppar, leur methode de preparation et leur utilisation dans des compositions cosmetiques ou pharmaceutiques.
DE102007038251A1 (de) * 2007-08-13 2009-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Herstellverfahren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801990D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
MA26634A1 (fr) 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I

Also Published As

Publication number Publication date
MXPA02005223A (es) 2003-09-25
NO20022590D0 (no) 2002-05-31
AR033957A1 (es) 2004-01-21
TR200401716T4 (tr) 2004-09-21
US6750252B2 (en) 2004-06-15
DK1237856T3 (da) 2004-08-02
CN1206212C (zh) 2005-06-15
ATE266633T1 (de) 2004-05-15
EP1237856A1 (en) 2002-09-11
ZA200203798B (en) 2003-10-29
BR0016130A (pt) 2002-08-20
SE9904421D0 (sv) 1999-12-03
US20030149104A1 (en) 2003-08-07
EP1237856B1 (en) 2004-05-12
CA2392039A1 (en) 2001-06-07
AU2035101A (en) 2001-06-12
IL149517A (en) 2007-07-04
KR100787072B1 (ko) 2007-12-21
CN1402703A (zh) 2003-03-12
ES2219425T3 (es) 2004-12-01
PT1237856E (pt) 2004-08-31
TWI224590B (en) 2004-12-01
KR20020067537A (ko) 2002-08-22
DE60010747T2 (de) 2005-05-19
JP2003515583A (ja) 2003-05-07
DE60010747D1 (de) 2004-06-17
IL149517A0 (en) 2002-11-10
WO2001040172A1 (en) 2001-06-07
MY124727A (en) 2006-06-30
AU766533B2 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
DK1084102T3 (da) Nye 3-arylpropionsyrederivater og analoge
NO20022590D0 (no) Nye tri-substituerte fenylderivater og analoge
NO20033715D0 (no) Nye sammensetninger
DK1261585T3 (da) Substituerede indol-Mannichbaser
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
ATE361281T1 (de) Substituierte phenylderivate
ATE329566T1 (de) Pflaster mit magnetischer wirkung
NO20000677D0 (no) Brønnhode
ID28613A (id) Peralatan melingkar phasa-terkunci
IS5843A (is) Fenýl janþín (yanthine) afleiður
NO20020810D0 (no) Nye fenylpiperaziner
DK1237857T3 (da) Nye Phenalkyloxyphenylderivater
DE50013404D1 (de) Substituierte 2-dialkylaminoalkylbiphenyl-derivate
NO20015074L (no) Nye sammensetninger
DE50014402D1 (de) Schraubanker
DK1487778T3 (da) Substituerede 4 aminocyclohexanoler
TR200002831A3 (tr) Kinolin-4-Il türevleri I
DK1200423T3 (da) Substituerede pehnyluraciler
DK1112262T3 (da) Substituerede gamma-delta-lactamer og analoger deraf og anvendelser relateret dertil
SE0000413D0 (sv) Skruvtransportör
FI4052U1 (fi) Muuttokaappi
SE0202575D0 (sv) Tidsystem - NooN 50
FI991065A0 (fi) Sukelluslaitteisto
DK199900332U3 (da) Konservering af naturprodukter
GT200000036A (es) Nuevas dihidropirimidinas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application